Head-to-head dispatch
Bioverse vs FitRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Bioverse (GoBioverse) offers compounded semaglutide and tirzepatide plus brand-name Ozempic, Wegovy, and Mounjaro.
$129/mo (starting dose, compounded) sema · $399/mo (starting dose, compounded) tirz · Verified July 20, 2026
Marked down on: No visible LegitScript or PCAB accreditation
FDAWarning letter issued to Bioverse, Inc. dba Bioverse in September 2025. See the FDA warning-letter database.
Desk Score
FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.
$151/mo (quarterly plan, compounded) sema · Verified July 20, 2026
Marked down on: Insurance coordination may not work for all plans
FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.
FitRx takes this head-to-head with the higher Desk Score, 76/100 (C) against 49/100 (C) for Bioverse. Bioverse still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Bioverse
49/100
C
FitRx
76/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Bioverse | FitRx |
|---|---|---|
| Semaglutide | $129/mo (starting dose, compounded) | $151/mo (quarterly plan, compounded) |
| Tirzepatide | $399/mo (starting dose, compounded) | Not listed on FitRx's site (checked July 20, 2026) |
| Coverage | Not listed on Bioverse's site (checked July 20, 2026) | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Broad GLP-1 formulary with longevity add-ons. | Insured patients seeking brand-name GLP-1 access with compounded fallback. |
| Desk Score | 49/100C | 76/100C |
The verdict
Desk pick — FitRxFitRx takes this head-to-head with the higher Desk Score, 76/100 (C) against 49/100 (C) for Bioverse. Bioverse still holds its ground where its strengths line up with yours.
Choose Bioverse if…
Broad GLP-1 formulary with longevity add-ons.
$129/mo (starting dose, compounded) sema · $399/mo (starting dose, compounded) tirz
FDAWarning letter issued to Bioverse, Inc. dba Bioverse in September 2025. See the FDA warning-letter database.
Choose FitRx if…
Insured patients seeking brand-name GLP-1 access with compounded fallback.
$151/mo (quarterly plan, compounded) sema · All 50 states
FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Bioverse · FitRx.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Bioverse vs CoreAge Rx
- CoreAge Rx vs FitRx
- Bioverse vs Effecty
- FitRx vs Vytora Health
- AgelessRx vs Bioverse
- Effecty vs FitRx
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.